I do think most people are missing the big picture here. The combo of LEI PYC and Sue Fletcher is HUGE. RNA therapy has been introduced to PYC. There are many genetic diseases that can be cured with this therapy, think of it as 1 step away from crisper but just as good, maybe more monetisable even.. If they have 3-4 candidates to roll out over the next 12 months there are great prospects for this company in sales of the cure for these diseases. Others will notice and want a piece of our platform( which is not being talked about much but it still is worth a lot to us as it puts us into a different category altogether).. I cant see anyone wanting to get out except in a staggered way over the next 15 years as if this all comes to fruition we will all be getting our investment back every year in dividends...and probably sooner than most people think.
PYC Price at posting:
5.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)